0
Views
0
CrossRef citations to date
0
Altmetric
RESEARCH ARTICLE

The Relationship between TNF-α, IL-1, IL-12, IL-17, IL-23, IL-36 Expression and Treatment Response in Psoriasis Histopathologically and Immunohistochemically

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Received 02 Nov 2023, Accepted 20 Jun 2024, Accepted author version posted online: 17 Jul 2024
Accepted author version

References

  • Griffiths CE, van de Kerkhof P, Czarnecka-Operacz M. Psoriasis and atopic dermatitis. Dermatology and therapy, 2017;7(1):31-41.
  • Özer İ, Temiz SA, Ataseven A, Dursun R, Uyar M, Özer M. Is prenatal testosterone- estrogen balance associated with Psoriasis?. Dermatol Ther 2020;33(6):e14213.
  • Temiz SA, Özer İ, Ataseven A, Dursun R, Uyar M. The effect of smoking on the psoriasis: Is it related to nail involvement?. Dermatol Ther 2020;33(6):e13960.
  • Delaporte E. Immune-mediated inflammatory diseases and psoriasis. Ann Dermatol Venereol 2008;135:269-274.
  • Ataseven A, Temiz SA, Eren G, Özer İ, Dursun R. Comparison of anti-TNF and IL-inhibitors treatments in patients with psoriasis in terms of response to routine laboratory parameter dynamics. Journal of Dermatological Treatment 2020;1-6.
  • Van den Reek JMPA, Zweegers J, Kievit W, Otero ME, Van Lümig PPM, Driessen RJB, et al. ‘Happy’drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practicecare: results from the Bio CAPTURE network. British Journal of Dermatology, 2014;171(5):1189-1196.
  • Griffiths CE, Strober BE, van de Kerkhof P, Ho V, Fidelus-Gort R, Yeilding N, et al. Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis. New England Journal of Medicine, 2010;362(2):118-128.
  • Morar II, Tabăran FA, Mocan T, Jianu EM, Orăsan MS, Pop AD, et al. Immunohistochemical study of psoriatic plaques and perilesional skin in psoriasis vulgaris patients: A pilot study. Experimental and therapeutic medicine 2019;18(2):888-894.
  • Lowes MA, Suarez-Farinas M, Krueger JG. Immunology of psoriasis. Annual review of immunology 2014;32, 227-255.
  • Mitra A, Fallen RS, Lima HC. Cytokine-based therapy in psoriasis. Clinical reviews in allergy & immunology 2013;44(2):173-182.
  • Arican O, Aral M, Sasmaz S, Ciragil P. Serum levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators of inflammation 2005(5), 273-279.
  • Piskin G, Tursen U, Sylva‐Steenland RMR, Bos JD, Teunissen MBM. Clinical improvement in chronic plaque‐type psoriasis lesions after narrow‐band UVB therapy is accompanied by a decrease in the expression of IFN‐γ inducers–IL‐12, IL‐18 and IL‐23. Experimental dermatology 2004;13(12):764-772.
  • Lee E, Trepicchio WL, Oestreicher JL, Pittman D, Wang F, Chamian F, et al. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. The Journal of experimental medicine, 2004;199(1):125-130.
  • El-Leithy S, Sherif N, El-Arousy NH, El-Hilaly R, Shakweer MM. Cutaneous immunohistochemical expression of interleukin-23 receptor (IL-23R) in psoriasis and psoriatic arthritis patients: Relation to musculoskeletal ultrasound findings. The Egyptian Rheumatologist. 2020
  • Chiricozzi A, Suárez‐Fariñas M, Fuentes‐Duculan J, Cueto I, Li K, Tian S, et al. Increased expression of interleukin‐17 pathway genes in nonlesional skin of moderate‐to‐severe psoriasis vulgaris. British Journal of Dermatology, 2016;174(1):136-145.
  • Johansen C, Funding AT, Otkjaer K, Kragballe K, Jensen UB, Madsen M, et al. Protein expression of TNF-α in psoriatic skin is regulated at a post transcriptional level by MAPK-activated protein kinase 2. The Journal of Immunology 2006;176(3):1431-1438.
  • Kawaguchi M, Mitsuhashi Y, Kondo S. Overexpression of tumour necrosis factor‐α‐converting enzyme in psoriasis. British Journal of Dermatology, 2005;152(5):915-919.
  • Caldarola G, De Simone C, Carbone A, Tulli A, Amerio P, Feliciani C. TNFα and its receptors in psoriatic skin, before and after treatment with Etanercept. International journal of immunopathology and pharmacology 2009;22(4):961-966.
  • Yamamoto M, Imai Y, Sakaguchi Y, Haneda T, Yamanishi K. Serum cytokines correlated with the disease severity of generalized pustular psoriasis. Disease Markers 2013;34(3):153-161.
  • Solberg SM, Sandvik LF, Eidsheim M, Jonsson R, Bryceson YT, Appel S. Serum cytokine measurements and biological therapy of psoriasis–Prospects for personalized treatment?. Scandinavian journal of immunology, 2018;88(6):e12725.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.